Profil
Xue Fei Huang is the founder and current Chief Scientific Officer of Iaso Therapeutics, Inc. which is founded in 2018.
Postes actifs de Xue Fei Huang
| Sociétés | Poste | Début |
|---|---|---|
Iaso Therapeutics, Inc.
 Iaso Therapeutics, Inc. BiotechnologyHealth Technology Iaso Therapeutics, Inc. is a start-up company spun out from Michigan State University. The company is based in East Lansing, MI. Iaso Therapeutics is dedicated to developing next-generation vaccines to enhance human health and treat diseases. The company was founded in 2018 by Dr. Huang, a MSU Foundation Professor jointly appointed in the Department of Chemistry and the Department of Biomedical Engineering. Robert Forgey has been the CEO of the company since 2020. | Fondateur | 01/01/2018 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Iaso Therapeutics, Inc.
Iaso Therapeutics, Inc. BiotechnologyHealth Technology Iaso Therapeutics, Inc. is a start-up company spun out from Michigan State University. The company is based in East Lansing, MI. Iaso Therapeutics is dedicated to developing next-generation vaccines to enhance human health and treat diseases. The company was founded in 2018 by Dr. Huang, a MSU Foundation Professor jointly appointed in the Department of Chemistry and the Department of Biomedical Engineering. Robert Forgey has been the CEO of the company since 2020. | Health Technology |
